Newsy's Latest Health News

The video discusses the FDA's anticipated authorization of Moderna's COVID-19 vaccine for emergency use, following a recommendation from an advisory panel. This would make it the second vaccine available in the US after Pfizer's. Additionally, Johnson & Johnson is conducting a large-scale vaccine trial and expects interim data by January, with plans to seek emergency use authorization if results are favorable. The video concludes with acknowledgments to Kaiser Health News for their contributions.

What is the age group for which Moderna's COVID-19 vaccine is expected to be authorized?

• 16 and older

• 21 and older

• 12 and older

• 18 and older

Which COVID-19 vaccine was approved for emergency use in the US before Moderna's?

• Novavax

• Johnson & Johnson

• Pfizer

• AstraZeneca

How many participants has Johnson & Johnson enrolled in its late-stage COVID-19 vaccine trial?

• 15,000

• 60,000

• 30,000

• 45,000

When does Johnson & Johnson expect to have interim data from its vaccine trial?

• By the end of December

• By the end of January

• By the end of February

• By the end of March

Why did Johnson & Johnson pause its vaccine trial in the US?

• To review data from other trials

• Because of an unexplained illness in a participant

• Due to a lack of participants

• To change the trial protocol